Navigation Links
IGF-1 EIA Endocrine Function 026-AC-27F1 Insulin Growth Factor

ProductsIGF-1 EIA Endocrine Function 026-AC-27F1 Insulin Growth Factor
Company ALPCO Diagnostics
Item IGF-1 EIA Endocrine Function 026-AC-27F1 Insulin Growth Factor
Features 
Description Insulin-like growth factor 1 (IGF-1) is a polypeptide of 70 amino acids (7650 daltons), and is one of a number of related insulin-like growth factors present in the circulation. The molecule shows approximately 50% sequence homology with proinsulin and has a number of biological activities similar to insulin. The peptide is growth hormone (GH) dependent to a high degree, but there is growing evidence of GH-independent secretion. IGF-1 has numerous growth-promoting effects, including mitogenic effects and the promotion of cartilage sulphation. It also mediates growth promoting actions of growth hormone on skeletal and other body fluids. Almost all (>95%) of serum IGF-1 circulates bound to specific IGF binding proteins, of which six classes (IGF-BPs 1-6) are now recognised. BP3 is thought to be the major binding protein of IGF-1, forming a ternary complex of 140 000 daltons with IGF-1 and an acid-labile sub-unit. The measurement of serum IGF-1 is of recognised value in children with growth disorders and in the diagnosis and monitoring of acromegaly. IGF-1 concentrations change with age, nutritional status, body composition and growth hormone secretion. A single basal IGF-1 determination is useful in the assessment of short stature in children and in nutritional support studies of acutely ill patients. For the diagnosis of acromegaly, a single IGF-1 determination is considered more reliable than a random GH determination. Patient samples are incubated briefly with a reagent to inactivate binding proteins, and then diluted for assay. In the OCTEIA IGF-1 kit a purified sheep polyclonal anti-IGF-1 is coated onto the inner surface of polystyrene microtitre wells (the solid phase or capture antibody). The pre-treated, diluted sample is then incubated, together with horseradish peroxidase labeled monoclonal anti-IGF-1, in antibody coated wells for 2 hours at room temperature. The wells are washed and a single component chromogenic substrate (a formulation of tetramethylbenzidine) is added to develop color. The absorbance of the stopped reaction mixture is read in a microtitre plate reader, color intensity developed being directly proportional to the amount of IGF-1 present in the sample.
Info ALPCO DiagnosticsCall ALPCO Diagnostics to buy products (US and Canada only; other locations use number below) USACanada1-866-466-7731

Customer Service: (800) 592-5726
Web site: http://www.alpco.com

Related medicine products :

1. IGF-1 (Insulin-Like Growth Factor I)
2. Human Growth Hormone EIA Endocrine Function 025-BC-1033
3. IGF-BP3 EIA Endocrine Function 022-IGF-E03 Insulin Growth Factor binding protein
4. Lyphochek Endocrine Control
5. Near Functional Acuity - Fact101
6. MR 23 Multi-Function Programmable High and Low Speed Refrigerated Centrifuge.
7. BR 4i Compact Multi-Function Refrigerated Bench-Top Centrifuge.
8. CR 3i Compact Multi-Function Refrigerated Bench-Top Centrifuge.
9. Free T3 EIA Thyroid Function 025-BC-1006
10. Free T4 EIA Thyroid Function 025-BC-1008
11. TPO (Ab) RIA Thyroid Function 014-HD-90.1 Thyroid Peroxidase
Finnpipette Fixed Volume, 500ul
...omics, and value!, Comfortable feel and less hand...ner control while pipetting with smooth, light plu...asy decontamination and sterilization without the ...crometer for reproducible, accurate volume setting...
Eppendorf Research Series 2100 Fixed-volume Pipette, 500 l
Ovation BioNatural Pipette, one-stroke, fixed volume, 300L
Medicine Products:
(Date:11/24/2009)...ewswire/--TheBaylorCharlesA.SammonsCancerCenterhas...ialscooperativegroupsintheUnitedStates.Fundedbyres...tOncologyGroupconductsclinicaltrialstopreventandtr...ancersurvivors. ,, "Joiningthisprestigiousgroup...lstocancerpatientsinNorthTexas,"saidAlanM.Miller,M...
(Date:11/24/2009)...orkStateFraternalOrderofPolicedistributedturkeys,c...York ,, PORTJERVIS,N.Y.,Nov.24/PRNewswire-USNew...npartnershipwiththeNewYorkStateFraternalOrderofPol...lsNewYork,sChildDevelopmentCenter,ProjectDiscovery...achtoreceivefreeturkeys,ham,chickenandothertrimmin...
(Date:11/24/2009)...wire-USNewswire/--GovernorEdwardG.Rendelltodayanno...werevaccinatedduringtheweekendatpublichealthclinic...nts. ,, "Withthefederalgovernmentunabletoprovid...bilityofH1N1vaccine,distributionhasbeenchallenging...H1N1vaccinedistributionprocessinPennsylvania.Holdi...
(Date:11/24/2009)...re-USNewswire/--Dr.NelsonEscobar,aphysicianwiththe...eJamesBradyAward.TheawardwaspresentedtohimbytheBra...lconferenceonOctober30,2009. ,, AccordingtotheB...onofhisexpertiseinaddressingthecomplexneedsofperso...ceptionalcareofhispatientsandtheirfamiliesastheyre...
(Date:11/24/2009)...ard off peripheral artery disease, researchers sa...-- Among people aged 75 and older, the herbal supp...s, stroke or death, a new study finds. , There ...ght help prevent the leg-circulation problem known...o contains nutrients called flavonoids, which are ...
Breaking Medicine News(10 mins):Health News:Baylor Sammons Cancer Center Joins One of Nation's Largest Cancer Clinical Trials Groups 2Health News:Fraternal Order of Police Provides Food and Hope for Families in Port Jervis this Thanksgiving 2Health News:Governor Rendell Announces 100,000 At-Risk Pennsylvanians Vaccinated at H1N1 Public Health Clinics; Addresses Future Vaccine Distribution Plans 2Health News:Marianjoy Medical Group Physician Receives James Brady Award 2Health News:Ginkgo Won't Prevent Heart Attack, Stroke in Elderly 2Health News:Ginkgo Won't Prevent Heart Attack, Stroke in Elderly 3
...ect in reversing the ultimate problem of gastroeso...ds//. A recent study by Gerson at the Stanford...ple suffering from heartburn can eat chocolate, fr...ents walk into her clinic upset, having been advis...
...earch, which revealed that there was no link betwe...t in British nuclear tests in Australia in the 195...ing to the he Federal Government commissioned stud...er Veterans Affairs Minister, Bruce Billson, said ...
...rted among Intravenous drug users (IDUs). Accordi... control and prevention (CDC) and South Africa Med...sharing and using the same needle up to 15 times e...cy Plan for AIDS Relief Meeting which was held at ...
...'s booming healthcare market, infrastructure inves... placement of Rs 90 crore in Bangalore-based Manip...in the firm. The investment was made by IDFC ...iod of five years. We will also have an option to ...
...e the passengers to risk of contacting disease lik...ited Nations //health agency has issued fresh guid...with multi-drug resistant tuberculosis must postpo...e on a commercial aircraft, where the quality of a...
...has been receiving incessant calls from four group...were infected with HIV and hepatitis C after recei...Government bill that deals with the long standing ...dress the difficulties in insurance experienced by...
Other Medicine News:Health News:No More Dietary Restriction for Heartburn Patients - Study Says 2Health News:No More Dietary Restriction for Heartburn Patients - Study Says 3Health News:No More Dietary Restriction for Heartburn Patients - Study Says 4
(Date:11/24/2009)...J.andNEWYORK,Nov.24/PRNewswire/-- EisaiInc.andPfi...ration(FDA)hasacceptedforreviewEisai,sNewDrugAppli...HClextendedrelease)tabletsforthetreatmentofmoderat...ormulationcontains23mgofdonepezilHClinanextendedre...wsforgradualreleaseofthedrug.TheNDAisbasedonahead-...
(Date:11/24/2009)...ov.24/PRNewswire/--ZargisMedicalCorp.,asubsidiaryo...sCorporateResearch(NYSE: SI ),todayannouncedthatit...2009episodeofCBS, TheEarlyShow duringasegmentinwhi...eviewedfivewinningproductsfromthepublication,s2009...dely-viewedtelevisionmorningnewstalkshowbroadcastb...
(Date:11/24/2009)...PRNewswire/--AmbitBiosciencesCorporationannouncedt...AC220,anovelsecondgenerationFLT3inhibitor,inAMLatt...)tobeheldinNewOrleans,LA,December5-8,2009.Anoralpr...lPhaseImonotherapysafetystudyinadultswithacutemyel...bepresentedevaluatingtheeffectofAC220monotherapyan...
Breaking Medicine Technology:FDA Accepts Once Daily 23 mg Aricept(R) Extended Release NDA for Review 2FDA Accepts Once Daily 23 mg Aricept(R) Extended Release NDA for Review 3Zargis Cardioscan(TM) Featured on The Early Show on CBS 2Zargis Cardioscan(TM) Featured on The Early Show on CBS 3Ambit Biosciences Corporation Announces Presentations Profiling AC220 Clinical and Non-Clinical Data at 51st American Society of Hematology Annual Meeting 2Ambit Biosciences Corporation Announces Presentations Profiling AC220 Clinical and Non-Clinical Data at 51st American Society of Hematology Annual Meeting 3Facet Solutions Enrolls 100th Patient in US Pivotal IDE Study 6113 1Facet Solutions Enrolls 100th Patient in US Pivotal IDE Study 6113 2Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 6111 1Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 6111 2Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 6111 3Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 6111 4Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 6111 5Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 6111 6Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 6111 7Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 6111 8Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 6111 9Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 6111 10Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 6111 11Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 6111 12Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 6111 13Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 6111 14Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 6111 15Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 6111 16Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 6111 17Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 6111 18Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 6111 19Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 6111 20Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 6111 21Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 6111 22Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 6111 23Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 6111 24Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 6111 25Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 6111 26Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 6111 27Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 6111 28Boston Scientifics Urology Gynecology Products Featured in Studies at Global Congress 6109 1Boston Scientifics Urology Gynecology Products Featured in Studies at Global Congress 6109 2Boston Scientifics Urology Gynecology Products Featured in Studies at Global Congress 6109 3Boston Scientifics Urology Gynecology Products Featured in Studies at Global Congress 6109 4Boston Scientifics Urology Gynecology Products Featured in Studies at Global Congress 6109 5